Report on the first SLFN11 monothematic workshop

From function to role as a biomarker in cancer

Alberto Ballestrero, Davide Bedognetti, Domenico Ferraioli, Paola Franceschelli, Sana Intidhar Labidi-Galy, Elisabetta Leo, Junko Murai, Yves Pommier, Petros Tsantoulis, Valerio Gaetano Vellone, Gabriele Zoppoli

Research output: Contribution to journalArticle

3 Citations (Scopus)

Abstract

SLFN11 is a recently discovered protein with a putative DNA/RNA helicase function. First identified in association with the maturation of thymocytes, SLFN11 was later causally associated, by two independent groups, with the resistance to DNA damaging agents such as topoisomerase I and II inhibitors, platinum compounds, and other alkylators, making it an attractive molecule for biomarker development. Later, SLFN11 was linked to antiviral response in human cells and interferon production, establishing a potential bond between immunity and chemotherapy. Recently, we demonstrated the potential role of SLN11 as a biomarker to predict sensitivity to the carboplatin/taxol combination in ovarian cancer. The present manuscript reports on the first international monothematic workshop on SLFN11. Several researchers from around the world, directly and actively involved in the discovery, functional characterization, and study of SLFN11 for its biomarker and medicinal properties gathered to share their views on the current knowledge advances concerning SLFN11. The aim of the manuscript is to summarize the authors' interventions and the main take-home messages resulting from the workshop.

Original languageEnglish
Article number199
JournalJournal of Translational Medicine
Volume15
Issue number1
DOIs
Publication statusPublished - Oct 2 2017

Fingerprint

Biomarkers
Tumor Biomarkers
Manuscripts
Education
Topoisomerase I Inhibitors
Platinum Compounds
RNA Helicases
Topoisomerase II Inhibitors
DNA Helicases
Chemotherapy
Alkylating Agents
Carboplatin
DNA
Thymocytes
Paclitaxel
Ovarian Neoplasms
Interferons
Antiviral Agents
Immunity
Cells

Keywords

  • Biomarker
  • Breast cancer
  • Chemotherapy
  • Colorectal cancer
  • DNA damage repair
  • Immune system
  • Ovarian cancer
  • Prediction
  • Prognosis
  • SLFN11

ASJC Scopus subject areas

  • Biochemistry, Genetics and Molecular Biology(all)

Cite this

Report on the first SLFN11 monothematic workshop : From function to role as a biomarker in cancer. / Ballestrero, Alberto; Bedognetti, Davide; Ferraioli, Domenico; Franceschelli, Paola; Labidi-Galy, Sana Intidhar; Leo, Elisabetta; Murai, Junko; Pommier, Yves; Tsantoulis, Petros; Vellone, Valerio Gaetano; Zoppoli, Gabriele.

In: Journal of Translational Medicine, Vol. 15, No. 1, 199, 02.10.2017.

Research output: Contribution to journalArticle

Ballestrero, A, Bedognetti, D, Ferraioli, D, Franceschelli, P, Labidi-Galy, SI, Leo, E, Murai, J, Pommier, Y, Tsantoulis, P, Vellone, VG & Zoppoli, G 2017, 'Report on the first SLFN11 monothematic workshop: From function to role as a biomarker in cancer', Journal of Translational Medicine, vol. 15, no. 1, 199. https://doi.org/10.1186/s12967-017-1296-3
Ballestrero, Alberto ; Bedognetti, Davide ; Ferraioli, Domenico ; Franceschelli, Paola ; Labidi-Galy, Sana Intidhar ; Leo, Elisabetta ; Murai, Junko ; Pommier, Yves ; Tsantoulis, Petros ; Vellone, Valerio Gaetano ; Zoppoli, Gabriele. / Report on the first SLFN11 monothematic workshop : From function to role as a biomarker in cancer. In: Journal of Translational Medicine. 2017 ; Vol. 15, No. 1.
@article{a057d8203be14358a989a1427abe3e91,
title = "Report on the first SLFN11 monothematic workshop: From function to role as a biomarker in cancer",
abstract = "SLFN11 is a recently discovered protein with a putative DNA/RNA helicase function. First identified in association with the maturation of thymocytes, SLFN11 was later causally associated, by two independent groups, with the resistance to DNA damaging agents such as topoisomerase I and II inhibitors, platinum compounds, and other alkylators, making it an attractive molecule for biomarker development. Later, SLFN11 was linked to antiviral response in human cells and interferon production, establishing a potential bond between immunity and chemotherapy. Recently, we demonstrated the potential role of SLN11 as a biomarker to predict sensitivity to the carboplatin/taxol combination in ovarian cancer. The present manuscript reports on the first international monothematic workshop on SLFN11. Several researchers from around the world, directly and actively involved in the discovery, functional characterization, and study of SLFN11 for its biomarker and medicinal properties gathered to share their views on the current knowledge advances concerning SLFN11. The aim of the manuscript is to summarize the authors' interventions and the main take-home messages resulting from the workshop.",
keywords = "Biomarker, Breast cancer, Chemotherapy, Colorectal cancer, DNA damage repair, Immune system, Ovarian cancer, Prediction, Prognosis, SLFN11",
author = "Alberto Ballestrero and Davide Bedognetti and Domenico Ferraioli and Paola Franceschelli and Labidi-Galy, {Sana Intidhar} and Elisabetta Leo and Junko Murai and Yves Pommier and Petros Tsantoulis and Vellone, {Valerio Gaetano} and Gabriele Zoppoli",
year = "2017",
month = "10",
day = "2",
doi = "10.1186/s12967-017-1296-3",
language = "English",
volume = "15",
journal = "Journal of Translational Medicine",
issn = "1479-5876",
publisher = "BioMed Central Ltd.",
number = "1",

}

TY - JOUR

T1 - Report on the first SLFN11 monothematic workshop

T2 - From function to role as a biomarker in cancer

AU - Ballestrero, Alberto

AU - Bedognetti, Davide

AU - Ferraioli, Domenico

AU - Franceschelli, Paola

AU - Labidi-Galy, Sana Intidhar

AU - Leo, Elisabetta

AU - Murai, Junko

AU - Pommier, Yves

AU - Tsantoulis, Petros

AU - Vellone, Valerio Gaetano

AU - Zoppoli, Gabriele

PY - 2017/10/2

Y1 - 2017/10/2

N2 - SLFN11 is a recently discovered protein with a putative DNA/RNA helicase function. First identified in association with the maturation of thymocytes, SLFN11 was later causally associated, by two independent groups, with the resistance to DNA damaging agents such as topoisomerase I and II inhibitors, platinum compounds, and other alkylators, making it an attractive molecule for biomarker development. Later, SLFN11 was linked to antiviral response in human cells and interferon production, establishing a potential bond between immunity and chemotherapy. Recently, we demonstrated the potential role of SLN11 as a biomarker to predict sensitivity to the carboplatin/taxol combination in ovarian cancer. The present manuscript reports on the first international monothematic workshop on SLFN11. Several researchers from around the world, directly and actively involved in the discovery, functional characterization, and study of SLFN11 for its biomarker and medicinal properties gathered to share their views on the current knowledge advances concerning SLFN11. The aim of the manuscript is to summarize the authors' interventions and the main take-home messages resulting from the workshop.

AB - SLFN11 is a recently discovered protein with a putative DNA/RNA helicase function. First identified in association with the maturation of thymocytes, SLFN11 was later causally associated, by two independent groups, with the resistance to DNA damaging agents such as topoisomerase I and II inhibitors, platinum compounds, and other alkylators, making it an attractive molecule for biomarker development. Later, SLFN11 was linked to antiviral response in human cells and interferon production, establishing a potential bond between immunity and chemotherapy. Recently, we demonstrated the potential role of SLN11 as a biomarker to predict sensitivity to the carboplatin/taxol combination in ovarian cancer. The present manuscript reports on the first international monothematic workshop on SLFN11. Several researchers from around the world, directly and actively involved in the discovery, functional characterization, and study of SLFN11 for its biomarker and medicinal properties gathered to share their views on the current knowledge advances concerning SLFN11. The aim of the manuscript is to summarize the authors' interventions and the main take-home messages resulting from the workshop.

KW - Biomarker

KW - Breast cancer

KW - Chemotherapy

KW - Colorectal cancer

KW - DNA damage repair

KW - Immune system

KW - Ovarian cancer

KW - Prediction

KW - Prognosis

KW - SLFN11

UR - http://www.scopus.com/inward/record.url?scp=85030661034&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85030661034&partnerID=8YFLogxK

U2 - 10.1186/s12967-017-1296-3

DO - 10.1186/s12967-017-1296-3

M3 - Article

VL - 15

JO - Journal of Translational Medicine

JF - Journal of Translational Medicine

SN - 1479-5876

IS - 1

M1 - 199

ER -